Literature DB >> 14681506

Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

Yu Asanuma1, Annette Oeser, Ayumi K Shintani, Elizabeth Turner, Nancy Olsen, Sergio Fazio, MacRae F Linton, Paolo Raggi, C Michael Stein.   

Abstract

BACKGROUND: Premature coronary artery disease is a major cause of illness and death in patients with systemic lupus erythematosus, but little is known about the prevalence, extent, and causes of coronary-artery atherosclerosis.
METHODS: We used electron-beam computed tomography to screen for the presence of coronary-artery calcification in 65 patients with systemic lupus erythematosus (mean [+/-SD] age, 40.3+/-11.6 years) and 69 control subjects (mean age, 42.7+/-12.6 years) with no history of coronary artery disease. When calcification was detected, the extent was measured by means of the Agatston score. The frequency of risk factors for coronary artery disease was compared in patients and controls, and the relation between the patients' clinical characteristics and the presence or absence of coronary-artery calcification was examined.
RESULTS: The two groups were similar with respect to age, race, and sex. Coronary-artery calcification was more frequent in patients with lupus (20 of 65 patients) than in control subjects (6 of 69 subjects) (P=0.002). The mean calcification score was 68.9+/-244.2 in the patients and 8.8+/-41.8 (P<0.001) in controls. Levels of total, high-density lipoprotein, and low-density lipoprotein cholesterol were not elevated in patients with lupus, but levels of triglycerides (P=0.02) and homocysteine (P<0.001) were. Among patients with lupus, measures of disease activity were similar in those with and those without coronary-artery calcification, but those with calcification were more likely to be older (P<0.001) and male (P=0.008).
CONCLUSIONS: In patients with systemic lupus erythematosus, the prevalence of coronary-artery atherosclerosis is elevated and the age at onset is reduced. Early detection of atherosclerosis may provide an opportunity for therapeutic intervention. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14681506     DOI: 10.1056/NEJMoa035611

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  207 in total

1.  Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.

Authors:  R Lertnawapan; A Bian; Y H Rho; P Raggi; A Oeser; J F Solus; T Gebretsadik; A Shintani; C M Stein
Journal:  Lupus       Date:  2011-11-09       Impact factor: 2.911

2.  Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Authors:  Aleksandar K Stanic; Charles M Stein; Adam C Morgan; Sergio Fazio; MacRae F Linton; Edward K Wakeland; Nancy J Olsen; Amy S Major
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

3.  Association between depression and vascular disease in systemic lupus erythematosus.

Authors:  Carol M Greco; Tracy Li; Abdus Sattar; Amy H Kao; Natalya Danchenko; Daniel Edmundowicz; Kim Sutton-Tyrrell; Russell P Tracy; Lewis H Kuller; Susan Manzi
Journal:  J Rheumatol       Date:  2011-12-15       Impact factor: 4.666

4.  Epicardial adipose tissue is increased in patients with systemic lupus erythematosus.

Authors:  Aliza Lipson; Nikolaos Alexopoulos; Gregory Randell Hartlage; Chesnal Arepalli; Annette Oeser; Aihua Bian; Tebeb Gebretsadik; Ayumi Shintani; Arthur E Stillman; C Michael Stein; Paolo Raggi
Journal:  Atherosclerosis       Date:  2012-06-17       Impact factor: 5.162

Review 5.  Atherosclerotic vascular disease in the autoimmune rheumatologic patient.

Authors:  Rekha Mankad
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

Review 6.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

7.  Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus.

Authors:  Curtis L Gabriel; Patricia B Smith; Yanice V Mendez-Fernandez; Ashley J Wilhelm; Audrey Musi Ye; Amy S Major
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-02       Impact factor: 4.310

8.  Telomere length in patients with systemic lupus erythematosus and its associations with carotid plaque.

Authors:  Carly Skamra; Juanita Romero-Diaz; Alexander Sandhu; QiQuan Huang; Jungwha Lee; William Pearce; David D McPherson; Kim Sutton-Tyrrell; Richard Pope; Rosalind Ramsey-Goldman
Journal:  Rheumatology (Oxford)       Date:  2013-02-04       Impact factor: 7.580

Review 9.  Coronary artery calcification in chronic kidney disease: An update.

Authors:  Tomasz Stompór
Journal:  World J Cardiol       Date:  2014-04-26

Review 10.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.